The insulin-like growth factor I receptor (IGF-IR) activated by its ligands controls the proliferation of animal cells in at least 3 different ways: it is mitogenic, it is required for the establishment and maintenance of the transformed phenotype in several types of cells, and it protects from apoptosis, both in vivo and in vitro. The present application focuses on this third aspect, apoptosis, and it is intended to explore the mechanisms(s) by which the IGF-IR exerts its protective effect. In the first project, we wish to determine the domains in the IGF- IR that are necessary for its protective function, in analogy with the previously defined domains for growth and transformation. In the second project, we wish to dissect the signal transducing pathways of the IGF-IR that are involved in the protection from apoptosis. The third project explores the relationship between the IGF-IR and another major player in the apoptotic process: p53. In the fourth project, we wish to determine the relationship between the IGF-IR and other gene products, known to be important in apoptosis, such as tumor necrosis factor, and integrins. Finally, in the last project, a chance discovery that an Aderro vector caused an increase in the number of IGF-IRs, will allow us to ask whether certain Adeno proteins may have an effect on the expression of the receptor. We hope that these studies will yield insights on the mechanism of apoptosis at the basic level, and, at the same time, open the possibility of therapeutic applications.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM033694-14
Application #
2444580
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Project Start
1991-07-01
Project End
2000-06-30
Budget Start
1997-07-01
Budget End
1998-06-30
Support Year
14
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Thomas Jefferson University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
061197161
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Valentinis, B; Navarro, M; Zanocco-Marani, T et al. (2000) Insulin receptor substrate-1, p70S6K, and cell size in transformation and differentiation of hemopoietic cells. J Biol Chem 275:25451-9
Dews, M; Prisco, M; Peruzzi, F et al. (2000) Domains of the insulin-like growth factor I receptor required for the activation of extracellular signal-regulated kinases. Endocrinology 141:1289-300
Gatzka, M; Prisco, M; Baserga, R (2000) Stabilization of the Ras oncoprotein by the insulin-like growth factor 1 receptor during anchorage-independent growth. Cancer Res 60:4222-30
Valentinis, B; Romano, G; Peruzzi, F et al. (1999) Growth and differentiation signals by the insulin-like growth factor 1 receptor in hemopoietic cells are mediated through different pathways. J Biol Chem 274:12423-30
Reiss, K; Yumet, G; Shan, S et al. (1999) Synthetic peptide sequence from the C-terminus of the insulin-like growth factor-I receptor that induces apoptosis and inhibition of tumor growth. J Cell Physiol 181:124-35
Morrione, A; Plant, P; Valentinis, B et al. (1999) mGrb10 interacts with Nedd4. J Biol Chem 274:24094-9
Baserga, R; Morrione, A (1999) Differentiation and malignant transformation: two roads diverged in a wood. J Cell Biochem Suppl 32-33:68-75
Prisco, M; Romano, G; Peruzzi, F et al. (1999) Insulin and IGF-I receptors signaling in protection from apoptosis. Horm Metab Res 31:80-9
Peruzzi, F; Prisco, M; Dews, M et al. (1999) Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol Cell Biol 19:7203-15
Valentinis, B; Morrione, A; Peruzzi, F et al. (1999) Anti-apoptotic signaling of the IGF-I receptor in fibroblasts following loss of matrix adhesion. Oncogene 18:1827-36

Showing the most recent 10 out of 78 publications